Stenotrophomonas maltophilia but not by P. aeruginosa (14, 15) . Sensing occurs 23 through a histidine kinase PA1396 and leads to altered biofilm formation and 24 increased tolerance to several antibiotics including polymyxin B (14, 16) . Mutation of 25 PA1396 in the model strain PAO1 and several clinical isolates also leads to increased 26 tolerance to polymyxins B and E, suggesting DSF negatively modulates PA1396 27 activity (14, 16) . Detection of DSF family molecules in polybacterial infections, such as 28 those associated with cystic fibrosis (CF) where P. aeruginosa is present together 29 with other bacterial species, suggests interspecies signaling occurs in vivo and may 30 therefore lead to reduced efficacy of antibiotic therapy (14, 16) . 31
32
Here, we examine in more detail the role of PA1396 in sensing DSF family signals 33 and the potential of structural analogues of these signals to modulate PA1396 action. 34
In particular, we focus on the effects of DSF analogues on the PA1396-regulated 1 functions of biofilm formation and antibiotic tolerance, both in vitro and in murine 2 infection models. We demonstrate that only two of the five trans-membrane helices of 3 the input domain of PA1396 are required for DSF sensing, and DSF binding is 4 associated with enhanced PA1396 auto-phosphorylation. Furthermore, we found that 5 certain analogues of DSF block its ability to trigger auto-phosphorylation, which 6 coincide with specific alterations in the expression of a subset of P. aeruginosa genes, 7 reduction in biofilm formation and antibiotic tolerance using both in vitro and in vivo 8 infection models. Together, our findings indicate DSF-mediated interspecies 9 interactions may be influenced pharmacologically to improve the treatment of chronic 10 P. aeruginosa infections. 11
12

RESULTS
13
Examining the sensor input domain of PA1396 for DSF recognition 14
Although DSF perception by PA1396 requires its membrane-associated sensor input 15 domain (14) , the underlying molecular mechanism is unknown. As a first step to better 16 understand DSF sensing by PA1396, topological models of the protein were generated 17 with various prediction programs. Analyses with TMHMM, MEMSAT, SOSUI, and 18
HMMTOP suggested a topological model for PA1396 comprising five 19 transmembrane helices (TMHs), and with the N-and the C-terminus located in the 20 periplasm and cytoplasm, respectively (Fig. 1a) . In contrast, TOPPRED predicted a 21 relatively large cytosolic loop and a different location in the protein for some of the 22
TMHs. To experimentally assess the PA1396 topology, we constructed translational 23 fusions expressing hybrid proteins of the PA1396 input domain with either alkaline 24 phosphatase (PhoA) or β-galactosidase (LacZ) reporters as topological probes for 25 periplasmic and cytoplasmic locations, respectively. The hybrid proteins were 26 designed such that at least one fusion was placed in each predicted loop facing either 27 the periplasm or the cytoplasm (Fig. 1b) . 28
29
Plasmids carrying hybrid constructs were mobilized into E. coli and tested for PhoA 30
and LacZ activity in solid growth medium containing the substrates for either PhoA 31 (X-Phos) or LacZ (X-Gal), which permitted the visual estimation of the enzyme 32 activity of PA1396-PhoA and PA1396-LacZ fusion proteins, respectively. E. coli 33 expressing PhoA fusions to PA1396 at amino acid residues E4, N6, G66, A70, A137, 34 Q139 and Q141 exhibited clear PhoA + phenotypes (blue colonies), whereas PhoA 1 fusions to PA1396 at amino acid residues V37, E38, G107, G109 and L205 gave rise 2 to PhoA − phenotypes (white colonies). Conversely, bacteria expressing LacZ fusions 3 to PA1396 at amino acid residues V37, E38, G107, G109, L205, T240, L300 and 4 L381 exhibited LacZ + phenotypes (blue colonies). In contrast, LacZ fusions to 5 PA1396 at amino acid residues E4, N6, G66, A70, A137, Q139 and Q141 resulted in 6 LacZ − phenotypes (white colonies). These findings, also confirmed by quantitative 7 assays (Supplementary Table 1) , fit with a model of a five-TMHs protein and the 8 topology shown in Fig. 1b . 9
10
To test whether the predicted TMHs are important for DSF sensing, we constructed 11 PA1396 derivatives with progressive truncations at the N-terminus. Each truncated 12 PA1396 gene was cloned into pBBR1MCS and the constructs introduced into a 13 PA1396 deletion mutant. Bacteria expressing each of these transconjugants were 14 examined for their ability to respond to exogenous DSF by measuring pmrAB gene 15 expression using a pmr-gfp fusion, and for polymyxin B resistance (see Methods for 16 details). Removal of the first three TMHs did not affect the ability of PA1396 to 17 respond to DSF when compared to wild-type (Fig. 1c) . In contrast, any further 18 truncation led to a loss of DSF responsiveness (Fig. 1c) . Western blot analysis with 19 antisera against the His6 tag showed that all of the truncated proteins were expressed 20 to the same level as the wild type ( Supplementary Fig. 1 ). These results suggested 21
TMHs IV and V have a role in DSF sensing by PA1396. 22
23
To identify specific residues important for DSF binding and signal transduction, we 24 first focused on those conserved in PA1396 homologues from different bacterial 25 species. Conserved or semi-conserved residues in TMHs IV and V (Supplementary 26 Residues Y116, L117, T121, L123, L128, T135,  28   P136, W138, A140, P142, M144, L148, M149, V154, I155, P156 and Y158 were  29 replaced and the resulting variants assayed for their ability to confer response to DSF. 30
Bacteria expressing many of the variants did not exhibit significant changes in DSF 31
responsiveness. We identified a number of variants exhibiting decreased sensitivity to 32 DSF, such that higher concentrations were required to activate the pmr-gfp reporter 33 although significant activation occurred at concentrations in excess of 50 µM. These 34 variants had alanine replacements at T121, L123, L128, P142, L148, M149, V154 and 1 I155. Except for P142, all the variants with reduced DSF sensitivity were altered in 2 positions within the last two TMHs of PA1396. Variants with combinations of alanine 3 substitutions (such as T121A/L123A/ L128A) had an even further reduced sensitivity 4 (Fig. 1d) . The observed differences in the responses to DSF by the reporter strain 5
could not be attributed to differential protein expression since all replacements were 6 expressed to the same level as the parental protein ( Supplementary Fig. 1 ). Together, 7
we conclude residues in TMH-IV and TMH-V of PA1396 play a critical role in the 8 recognition of the DSF signal. 9 10 Physiochemical features of DSF important for recognition by PA1396 11
The DSF family comprises cis-2-unsaturated fatty acids of differing chain length, 12 methyl substitution and saturation (15) . Individual bacteria can produce multiple DSF 13 family signals, although often a single chemical species predominates. Previous work 14
showed that the configurational isomer trans-11-methyl-2-dodecenoic acid was 500-15 fold less effective than DSF in activation of pmrAB, whereas the corresponding 16 unsaturated fatty acids have little or no activity (14) . To examine the structural features 17 of the DSF signals important for PA1396 sensing in more detail, we synthesized a 18 panel of analogs differing from the DSF 'parent' molecule in chain length, position 19 and presence of methyl branching or with a trans configuration of the double bond. 20
Additional molecules were created by esterification, conversion to hydroxamic acids 21 or amides, and by incorporation of stable aromatic substituents to replace the 22 carboxylic acid moieties (see Fig. 2a ). This library of structural derivatives provided a 23 platform to define key structural features important for PA1396 sensing and signal 24 transduction activity. 25
26
The activity of the molecules in this panel was assayed by determining the relative 27 fluorescence of the reporter normalized by bacterial cell density (Fig. 2b) . Because the 28 minimum concentration of DSF (cis-11-methyl-2-dodecenoic acid) for significant 29 induction of pmr-gfp expression was 0.01 µM, the 27 DSF derivatives were examined 30 at this concentration. The results revealed that all fatty acids with a trans 31 configuration of the double bond at the 2-position render the molecule inactive (Fig.  32 2b), consistent with previous reports indicating this configuration is critical for DSF 33 activity (16) (17) (18) . However, the presence or the position of the methyl group at C-11 in 34 DSF was not essential for activity. Indeed, cis-2-tridecenoic acid (C9) and cis-2-1 dodecenoic acid (C2, BDSF) without the methyl substitution, as well as cis-7-methyl-2 2-dodecenoic acid (C6) and cis-8-methyl-2-dodecenoic acid (C5) where the methyl 3 group was transposed to the C-7 and C-8 positions, were equally effective in the 4 bioassay. In contrast, the fatty acid chain length played a major role in determining 5 bioactivity. cis-2-Unsaturated fatty acids with chain lengths of 12-14 carbons were 6 active whereas those with longer chains were not (Fig. 2b) . The introduction of a 7 second double bond in the chain also led to reduced activity, while derivatives in 8 which the carboxylic acid was esterified, converted to a hydroxamic acid or amide 9 derivative or replaced with a 2-amino pyridine moiety were all inactive. For each of 10 these derivatives, no activity was seen in the concentration range from 0.01 to 1000 11 µM. Interestingly, cis-2-tetradecenoic acid (C11), which is a naturally occurring 12 analogue first detected in Xylella fastidiosa (17) , was most effective in activating the 13 bioassay (Fig. 2c) . Strains carrying the T121A/L123A/ L128A replacement mutants 14 of PA1396 showed similar reduced responsiveness to both C11 and DSF (Fig. 2c) . 15 16 DSF analogues interfere with DSF signaling in P. aeruginosa 17
The structural analogues unable to trigger DSF-dependent responses were assessed for 18 inhibitory activity against DSF signaling. For these experiments, the molecules were 19 screened at 10 μM using P. aeruginosa grown with 50 μM DSF. Several compounds, 20 especially C12, C23 and C24 effectively repressed pmr-gfp expression (Fig. 3a) , 21 possibly acting as PA1396 receptor antagonists. None of the compounds affected 22 planktonic bacterial growth ( Supplementary Fig. 3 ). Dose response assays of each of 23 the three compounds revealed that compound 23 ((Z)-11-methyl-N-24 (methylsulfonyl)dodec-2-enamide; C23) was the most potent DSF antagonist showing 25 substantial inhibition at 0.1 μM (Fig. 3b) . 26
27
To examine if these compounds interfere directly with signal transduction through 28 PA1396, we assessed the effects of DSF and the putative antagonists on PA1396 auto-29 phosphorylation. For these experiments, MycHis-tagged PA1396 was expressed, 30 purified under native conditions, and reconstituted in liposomes where the protein 31 adopts an inside-out orientation in which the cytoplasmic histidine acceptor, histidine 32 kinase and receiver domains are surface exposed. The incorporation of PA1396 into 33 liposomes was confirmed by Western blot using anti-Myc antibody, whereas the 34 inside-out orientation can be surmised from the accessibility of ATP to the kinase site, 1 which allows auto-phosphorylation without disruption of the liposomes. Basal auto-2 phosphorylation of PA1396 in the liposomes was seen in the absence of any signal 3 molecule (Fig. 3c, Supplementary Table 2) . However, the addition of DSF to 4 PA1396-loaded liposomes increased the level of auto-phosphorylation dramatically, 5
an effect not seen in the presence of C23 (Fig. 3c, Supplementary Table 2 ). These 6 findings suggest C23 blocks the recognition of DSF by PA1396, which normally 7 mediates increased kinase activity. The observation that the T121A/L123A/L128A 8 mutant protein had a similar level of basal auto-phosphorylation as the parental 9 PA1396, which could not increase upon addition of DSF, also supports this 10 conclusion (Fig. 3c, Supplementary Table 2) . Further, the latter result agrees with the 11 observation that T121A/L123A/L128A has a substantially reduced response to DSF in 12 vivo as measured by the pmr-gfp reporter bioassay (Fig. 1d) . 13
14
We previously found that DSF alters the expression levels of P. aeruginosa genes 15 implicated in virulence, biofilm formation and stress tolerance (14) . In this study, we 16 assessed the effect of C23 on DSF-regulated functions by qRT-PCR using a subset of 17 11 DSF-regulated genes. These included genes involved in iron uptake (PA4358, 18 PA4359) and antibiotic resistance (PA4599, PA4774-PA4777). For these experiments, 19 P. aeruginosa was grown in artificial CF sputum medium with and without DSF 20 supplementation, and with both DSF and C23. Cultures were assayed at early log 21 phase (OD600 of 0.6). For several of the genes tested, the addition of C23 in the 22 growth medium reduced the level of expression seen with DSF alone and in some 23 cases (e.g. PA2966, PA5505) the effects on expression were reversed (Fig. 3d) . These 24 experiments were repeated with the PA1396 mutant strain, demonstrating that the 25 addition of DSF or C23 had no effect on the level of gene expression (Supplementary 26 promotes persistent infection in vivo (14, 16, 18) . We examined if C23 interferes with 34 biofilm formation using a co-culture system in which P. aeruginosa biofilms were 1 allowed to form on human lung epithelial cells upon addition of 1 µM DSF (16) . C23 at 2 concentrations as low as 0.5 µM C23 led to reduced biofilm formation in the presence 3 of DSF (Fig. 4a) . Intriguingly, addition of C23 alone caused a reduction of biofilm 4 development (Fig. 4a) . In contrast, the PA1396 mutant formed more biofilm than the 5 parental strain, but biofilm formation was not significantly altered by either DSF or 6 C23 ( Supplementary Fig. 5a ). Biofilm formation on a glass surface was also assayed 7 by crystal violet staining. Similar effects of DSF and C23 on biofilm biomass as in the 8 co-culture experiments were observed (Fig. 4b) including the ability of C23 alone to 9 inhibit biofilm formation. These effects were not seen in experiments using the 10 PA1396 mutant strain ( Supplementary Fig. 5b ). 11
12
To determine whether C23 modulates bacterial behavior during infections, C57BL/6 13 mice were inoculated intranasally with suspensions of P. aeruginosa supplemented 14 with C23, DSF or C23 with DSF. As a control, bacterial inocula were suspended in 15 PBS alone. At 24 h post infection, the P. aeruginosa PAO1 bacterial load was quite 16 considerable in the control animals. However, in the presence of C23, the number of 17 bacteria was considerably reduced. With DSF alone, higher numbers of bacteria were 18 seen after 24 h than in the control (Fig. 4c ), in agreement with previous trends seen in 19 other in vivo models (16) . With C23 in combination with DSF, the bacterial load was 20 reduced when compared to DSF alone ( Table 3) . While many of these 30 differentially expressed genes were originally annotated as hypothetical proteins, 31 several encode factors required by P. aeruginosa for growth and/or host colonization 32 of the host; these genes included norB (PA0524), popD (PA1709), sphA (PA2659) 33 and narK (PA3876). Additional regulated genes encoded factors that contribute to P. 34 aeruginosa virulence and biofilm formation such as the mexC (PA4599), pmr operon 1 (PA4774, PA4776, PA4777) and exoS (PA3841). 2 3 Addition of DSF and C23 significantly altered expression of 51 genes (Fig. 4d) . 4
Comparison with the effects of DSF alone showed expression changes in 21 genes 5 occurred in both treatments (DSF vs DSF plus C23) with all 21 of these genes altered 6 in the same direction. The expression level (fold change in expression) of these genes 7 was reduced in DSF plus C23 treatment when compared with the DSF treatment alone 8 (Supplementary Table 3 ). Further, some genes significantly regulated by DSF showed 9 no significant alteration in the presence of DSF and C23. Examples of this group of 10 genes include popD (PA1709) and pmr operon genes (PA4774, PA4776, PA4777). 11
Also, various genes showed a significant alteration in expression in response to DSF 12 plus C23, but not to DSF alone (Fig. 4d, 4e ). Selected genes were examined using 13
qRT-PCR to confirm the alteration in expression as revealed by the microarray (Fig.  14   4e) . Together, the combined results of the experiments described above show that C23 15
is not only able to inhibit DSF-activated responses in vitro and in vivo, but also has a 16 broader effect on gene expression independent of DSF-regulated responses. 17
18
The effect of C23 alone on gene expression was examined in a separate experiment on 19 bacteria grown in artificial sputum medium in the presence or absence of the 20 compound at 50 μM. RNA was extracted from these cultures and the level of 21 expression of selected genes examined by qRT-PCR. Of the genes examined, gcdH 22 (PA0447) and murA (PA4450) appeared to have elevated expression as a response of 23 C23 addition to P. aeruginosa PAO1, but showed little or no response to DSF 24 ( Supplementary Fig. 6 ). 25
26
The DSF analogue C23 improves antibiotic efficacy 27
Perception of DSF by P. aeruginosa mediated by PA1396 leads to increased 28 expression of the pmrAB operon and the concomitant increased level of resistance to 29 the cationic antimicrobial peptides polymyxin B and E (14, 16) . Further, DSF increases 30 tolerance to polymyxin B in P. aeruginosa biofilms-airway epithelial cells co-31
cultures (16) . These observations prompted us to examine the influence of C23 on the 32 sensitivity of P. aeruginosa to antibiotics. As expected, addition of DSF led to pmrAB 33 up-regulation and an increased resistance to polymyxin B (Fig. 5a, b) . By contrast, 34 addition of C23 plus DSF led to a marked reduction in pmrAB expression and reduced 1 resistance to polymyxin B. Although the pmrAB expression level in response to C23 2 alone was close to wild-type, C23 did appear to slightly enhance the activity of 3 polymyxin B against PAO1 (Fig. 5a ). We also examined the influence of DSF and 4 C23 singly and in combination in resistance to other classes of antibiotics used in 5 treatment of P. aeruginosa. Addition of DSF to the cultures led to increased resistance 6 to tobramycin and nalidixic acid but had no effect on carbapenem resistance. The 7 effect of DSF on increased tobramycin and nalidixic acid resistance was reversed by 8 C23 (Supplementary Fig. 7) . 9
10
To validate these results in other strains, we examined a panel of P. aeruginosa 11 clinical isolates and the data revealed that addition of DSF led to a significant increase 12 in the expression of pmrAB in each of these strains (Fig. 5b) . However, addition of 13 C23 reversed this DSF-induced effect in all strains, whereas C23 alone gave only 14 modest or no increase in expression. In all of these cases, changes in pmrAB 15 expression were associated with a concomitant alteration in resistance to polymyxin 16 B, as seen with PAO1 ( Supplementary Fig. 7) . Further, addition of C23 also reversed 17
DSF-induced tobramycin tolerance in the clinical isolates, which decreased in all 18
strains ( Supplementary Fig. 8 ). The PA1396 mutant in PAO1 showed increased 19 resistance to polymyxin B, an effect that could not be reversed by addition of C23, as 20 expected. To determine whether PA1396 was also required for the response of clinical 21 isolates of P. aeruginosa to C23, we created PA1396 gene disruption mutants in five 22 of them, which were selected because of their intrinsically higher level of pmrAB 23 expression and polymyxin resistance. None of the mutant strains responded to C23, 24 confirming the C23 antagonist effect on DSF is mediated by PA1396 (Supplementary 25 Fig. 9) . 26
27
We also assessed the effect of C23 on the efficacy of tobramycin treatment in the 28 C57BL/6 mouse lung infection model. Mice were infected with 1 × 10 7 CFU of PAO1 29 and treated by inhaling PBS with or without C23. Tobramycin was administered at a 30 concentration of 30 mg/kg one hour after infection, as previously reported (19, 20) . The 31 lung bacterial load was determined 24 h post-infection. Control mice infected with P. 32 aeruginosa and inhaled PBS exhibited considerable colonization (Fig. 5c) , which was 33 reduced by tobramycin treatment. However, adding C23 with tobramycin resulted in a 34 larger decrease of the bacterial load than that seen with tobramycin alone (Fig. 5c).  1 The kinetics of clearance of the PA1396 mutant strain from mice not treated with 2 antibiotics was similar to that of mice infected with PAO1. Together, these results 3 demonstrate that C23 treatment leads to reduced resistance of P. aeruginosa 4 laboratory and clinical strains to distinct antibiotics both in vitro and in vivo during 5 infection, an effect manifested through a functional PA1396 sensor kinase. 6 7 DISCUSSION 8
This study provides a detailed characterization of the membrane topology of PA1396 9 including the identification of its input domain, which has considerable sequence 10 similarity with the input domain of RpfC, the sensor histidine kinase for DSF-11 mediated cell-to-cell signalling in Xanthomonas campestris pv. campestris (15, 23) . 12
However, significant differences between PA1396 and RpfC also exist. RpfC contains 13 a short N-terminal periplasmic region implicated in DSF binding (24) , suggesting DSF 14 is captured in the periplasmic space. Residue E19, which is conserved in all 15 homologues with the RpfC-related input domain, is among various key residues for 16 DSF binding in RpfC (14, 24) . In P. aeruginosa PA1396, the corresponding residue is E8, 17 also in the N-terminal periplasmic region. However, deletion of a significant part of 18 the N-terminal region of PA1396 has no effect on DSF sensing by P. aeruginosa. 19
Unlike RpfC, our results indicate the DSF binding capability of PA1396 requires 20 residues in TMHs IV and V. This suggests that DSF likely interacts with residues in 21 these TMHs at the membrane level. 22
23
The PA1396 recognition of DSF shares features with the CqsS system of Vibrio 24 cholerae, which is responsible for detection of the quorum-sensing signal CAI-1 (S-3-25 hydroxytridecanone). Both CqsS and PA1396 have complex membrane spanning 26 domains with multiple TMHs and periplasmic and cytoplasmic loops of limited size 27 and both recognise ligands with alkyl chains of medium length and an amphipathic 28 nature. Nevertheless, substantial differences between the systems occur. In CqsS, 29 conserved residues in the first three (of six) TMHs are obligatory for CAI-1 ligand 30 binding and subsequent signal transduction. Further, residues in the fourth 31 transmembrane helix enable CqsS to discriminate between CAI-1 and amino-CAI-1 32 and residues in the fifth TMH has roles in restricting ligand head group size and tail 33 length (25) . In contrast, PA1396 truncation experiments suggest that the first three 34
TMHs of the protein are dispensable for DSF perception. However, whether THMs I-1
III of PA1396 have roles in detection of other ligands is unknown. 2 3
Previous work on interspecies signaling in P. aeruginosa demonstrated that the cis-2-4
(at position 11 in DSF) but was partially reduced by introducing a second double bond. 13
Notably, a derivative of DSF with a second double bond (cis, cis-11-methyldodeca-14 2,5-dienoic acid) occurs naturally in various Xanthomonas species, but also has a 15 reduced ability compared to DSF to trigger DSF-regulated genes (18) . Further, 16 interspecies signaling in P. aeruginosa depends on the chain length of the cis-17 unsaturated fatty acid; molecules with chain lengths longer than 14 (this work) and 18 less than 12 (15, 18, 21, 22) have no activity. In particular, PA1396 does not respond to 19 cis-2-decenoic acid, a molecule produced by P. aeruginosa and which is implicated in 20 biofilm dispersal (15, 23) . 21
22
We demonstrate that DSF and cis-unsaturated fatty acid analogues enhance the 23 tolerance of P. aeruginosa to a range of antibiotics including polymyxins, tobramycin 24 and nalidixic acid; this action requires the sensor kinase PA1396. In contrast, Deng 25 and colleagues (26) reported that both DSF and its analogues promote sensitivity of 26 several Gram-positive pathogens including Bacillus cereus and Staphylococcus 27 aureus to various antibiotics including kanamycin and gentamicin. The molecular 28 mechanisms underlying these effects in B. cereus are unclear, but it is intriguing that 29 cis-and trans-2-unsaturated fatty acids are equally effective in inducing the response. An example is infection associated with cystic fibrosis (CF), where P. aeruginosa can 4 occur together with S. maltophilia and Burkholderia species, both of which produce 5 DSF and BDSF. The detection of DSF and BDSF signals at physiologically relevant 6 levels in the sputum of CF patients supports the contention that interspecies signaling 7 may occur in these infections, where it may affect the antibiotic sensitivity of P. work will be directed at identifying these components. 25
26
In conclusion, pharmacological inhibition of DSF-mediated interspecies signaling in 27 P. aeruginosa using a DSF analogue potential has identified a potential lead 28 compounds for molecules that could be used as antibiotic adjuvants to control 29 diseases caused by this human pathogen. ; Na2HPO4 2H2O, 6 g l Cultures were also grown in artificial sputum medium which comprises: 5 g mucin 13 from pig stomach mucosa (Sigma), 4 g DNA (Fluka), 5.9 mg diethylene triamine 14 pentaacetic acid (Sigma), 5 g NaCl, 2.2 g KCl, 5 ml egg yolk emulsion (Oxoid) and 15 5 g amino acids per 1 l water (pH 7.0) (16, 19) . The antibiotics used included tobramycin, 16 polymyxin, kanamycin, rifampicin, gentamycin, spectinomycin, nalidixic acid, 17 carbapenem and tetracycline at the indicated concentrations. 18
19
DNA manipulation 20
Molecular biological methods such as isolation of plasmid and chromosomal DNA, 21 PCR, plasmid transformation, as well as restriction digestion were carried out using 22 standard protocols. PCR products were cleaned using the Qiaquick PCR purification 23 kit (Qiagen) and DNA fragments were recovered from agarose gels using Qiaquick 24 minielute gel purification kit (Qiagen). Oligonucleotide primers were purchased from 25 Sigma-Genosys. Primer sequences are provided in Supplementary Table 5 . 26
27
Cloning the PA1396 gene 28
The DNA fragments encoding the full-length PA1396 protein or truncation of interest 29 were synthesized by Gene Oracle (Santa Clara, USA) in pGOv4 and sub-cloned into 30 pET47b, pME6032 or pBAD/Myc-His before transformation into E. coli BL21 (DE3). 31
Genomic regions are described in Supplementary Table 5 . BL21 (DE3) cells were 32 grown in LB media and induced with 0.25 mM IPTG; protein overexpression was 33 carried out at 37°C for 1 h. Purification was achieved by Ni 2+ affinity chromatography 34 using the N-terminal His6 tag. 1 2
Construction of targeted PA1396-phoA and PA1396-lacZ fusions 3
Trans membrane domain (TMD) predictions of the P. aeruginosa PA1396 protein 4 were obtained using the TOPRED (27) , TMHMM (28) , DAS-TMFILTER (29, 30) SOSUI (31) 5
and HMMTOP (32) programs, each with their default settings. 6 7 Suitable fusion sites in the periplasmic and cytoplasmic loops were identified using a 8 consensus based on the TMS prediction data obtained (Supplementary Fig. 1 ). The 9 sites selected correspond to amino acids E4, N6, V37, E38, G66, A70, G107, G109, 10 A137, Q139, Q141 and L205. The DNA fragments encoding the proteins of interest 11 were synthesized by Gene Oracle (Santa Clara, USA) in pGOv4 and sub-cloned into 12 topology reporter plasmids phoA (pRMCD28) and lacZ (pRMCD70). Genomic 13 regions are described in Supplementary 
Synthesis of DSF analogues 1
The starting point for the synthesis of cis-2-dodecenoic acid C2 (BDSF) and 11-2 methyldodec-2-enoic acid C1 (DSF) involved a Swern oxidation of the starting 3 alcohol with dimethyl sulfoxide (DMSO) and oxalyl chloride at -78 °C to 4 corresponding aldehydes decanal and 11-methyldecanal (35) . A subsequent Wittig 5 reaction of the purified aldehyde with the modified Horner-Wadsworth-Emmons 6 phosphonate salt ethyl [bis(2,2,2-trifluoroethoxy)-phosphinyl]acetate in the presence 7 of sodium hydride (NaH) in THF afforded both the cis-and trans-α,β-unsaturated 8 esters, ethyl dodec-2-enoate and ethyl 11-methyldodec-2-enoate (36) . Hydrolysis of the 9 cis-α,β-unsaturated esters with lithium hydroxide (LiOH) in THF:MeOH:H2O (2:1:1 10 (v/v/v)) gave required products C2 and C1 (37, 38) . Treatment of C1 with 11 propylphosphonic anhydride and cyclopropylamine gave the required amide 12 analogue (39) . DSF antagonist C23 was prepared by way of an EDCI-mediated 13 coupling of C1 with methanesulfonamide in the presence of dimethylaminopyridine 14 and subsequent isolation of the desired cis-isomer by reverse phase HPLC. All the 15 chemicals and reagents were purchased from Sigma-Aldrich unless otherwise stated. HMQC spectra were performed by Bruker Avance 500 spectrometer. Mass spectra 25
ESI-MS and High-Resolution Mass Spectra ESI-MS were performed on a 26
Waters/Micromass: LCT Premier Time of Flight and a Quattro Micro triple 27 quadrupole instruments respectively. Infrared spectra were measured using NaCl 28 plates on a Perkin Elmer paragon 1000 FT-IR spectrometer. 29
30
DSF bioassays 31
The original DSF bioassay is based on its ability to restore endoglucanase production 32 to rpfF mutant of Xcc as described in (40) . DSF activity was expressed as the fold 33 increases in endoglucanase activity over the control. We also used the bioassay 34 previously described (16) that relies on DSF-dependent induction of fluorescence (pmr-1 gfp) in P. aeruginosa PAO1. 2 3
Reconstitution and phosphorylation of PA1396-His in liposomes 4
Using a variation in the method previously described (41, 42) , E. coli strains containing 5 pBAD/Myc-His (PA1396-pBAD/Myc-His) were induced with 0.2% arabinose and 6 purified through nickel columns according to the manufacturer's instructions (Qiagen). 7
Liposomes were reconstituted as previously described (24, 41) . Briefly, 50 mg of E. coli The samples were run on SDS/PAGE without boiling and visualized using a 34 Molecular Dynamics PhosphorImager. These were quantified by ImageJ software. 1 2
Biofilm Assays 3
Biofilm was assessed by attachment to glass and was determined by crystal violet 4 staining. Log-phase-grown bacteria were diluted to OD600 nm = 0.02 in LB broth and 5 5 ml was incubated at 37°C for 24 h in 14-ml glass tubes. After gently pouring off the 6 media, bacterial pellicles were wash 7 ed twice with water and were then stained with 0.1% crystal violet. Tubes were 8 washed and rinsed with water until all unbound dye was removed. Bound crystal 9 violet was eluted in ethanol and measured at OD595. Three independent assays were 10 carried out for each strain. 11
12
Polymyxin killing curves 13
Killing curves were carried out at 37°C temperature as previously described (14, 16) . In 14 short, mid-log phase cultures (OD600 0.4-0.6) of PAO1 wild-type strain, PAO1 15 supplemented with 50 µM DSF or PA1396 mutant grown in BM2 medium 16 supplemented with 0.5 mM and 2 mM Mg 2+ were diluted 1:100 into 30 mM sodium 17 phosphate buffer, pH 7.0, containing 4 μg ml -1 of polymyxin B sulphate and 5 μg ml -1 18 polymyxin E sulphate (Sigma). Samples were shaken gently, and aliquots removed at 19 specified time intervals were assayed for survivors by plating appropriate dilutions 20 onto LB agar. 21
22
Infection and treatment of animals 23
All animal experiments were approved by the Animal Ethics Committees of Queens 24
College Belfast and Nanyang Technological University. Mouse infection was 25 performed using a variation on the mouse model described in (16, 43) . Briefly, P. 26 aeruginosa strains were grown in Luria broth at 37 °C overnight with shaking, after 27 
Gene expression-profiling experiments 13
For the in vivo RNA samples, infected animals as described above were euthanized 14 ~24 h post-infection. RNA was isolated from airway homogenate pellets using Trizol 15 according to the manufacturer's instructions. Samples were treated with DNAse, then 16 rRNA was removed from 1 to 5 μg of total RNA using the RiboZero kit for Gram-17 negative bacteria (Epicentre). rRNA-depleted samples were concentrated by EtOH 18 precipitation. cDNA synthesis and hybridization to Affymetrix GeneChip P. (with 50 µM DSF-like signal molecules if used). Cultures were harvested during mid-27 log phase (OD600 = 0.6) and RNA was extracted using the High Pure RNA Isolation 28 Kit (Roche). The expression of genes was monitored by qRT-PCR, as described 29 previously (44, 45) . 30
31
Statistical Analysis 32
Significant differences between the means plus or minus standard deviations (SDs) of 33 different groups were examined using a two-tailed unpaired Student's t test. A P value 34 of less than 0.05 was regarded as statistically significant. All variables remained 1 significant after multiple testing. 
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